A pre-clinical stage biopharmaceutical company, InMed Pharmaceuticals, Inc. (OTCQB: IMLFF) has revealed two additions to its drug development pipeline.
A pre-clinical stage biopharmaceutical company, InMed Pharmaceuticals, Inc. (OTCQB: IMLFF) has revealed two additions to its drug development pipeline.
India Globalization Capital, Inc. (NYSE MKT: IGC), a developer of cannabis-based therapies to treat a variety of life-altering conditions, this morning announced the sale of its investment interest in Brilliant Hallmark for a consideration of four million shares of IGC.
India Globalization Capital, Inc. (NYSE MKT: IGC), a developer of cannabis-based therapies to treat a variety of life-altering conditions, this morning announced its filing of a provisional patent for the treatment of multiple types of eating disorders by a method and combination of cannabis extracts and other compounds.
Advancements continue to be made in various CBD extractions as the demand for cannabis extracts continues to climb at a high rate. Cannabidiol (CBD) is one of the most important healing substances, with a strong anti-inflammatory effect and without a psychotropic (narcotic) effect.
Canaccord Genuity analyst Neil Maruoka thinks Canopy Growth Corp. (TSX:WEED) is the “dominant player” in the Canadian cannabis sector, but says the company’s stock is fully valued at current levels.
India Globalization Capital (NYSE: IGC) was recently featured in an article detailing the company’s strategic move to the cannabis industry and future plans for the company. In the past, IGC was a company primarily focused on the beneficiation of iron ore.
Canaccord Genuity analyst Neil Maruoka thinks Canopy Growth Corp. (TSX:WEED) is the “dominant player” in the Canadian cannabis sector, but says the company’s stock is fully valued at current levels.
Agritek Holdings, Inc. (OTC:AGTK), is completing a land purchase contract on an additional thirty-five acre property located in Pueblo County, Colorado. The property will be owned wholly by Agritek Holdings Inc. and will be managed on behalf of Agritek by licensed cultivator partners.
Alternate Health Corp. (CSE:AHG,OTC:ATEHF) announced a non-brokered private placement with gross proceeds of CAD $7,569,055 (USD $5,602,834).
Invictus MD (CSE:IMH, OTC:IVITF) reports that Future Harvest Development Ltd. (of which Invictus MD currently owns 82.5%) has generated $1.578 million in revenue.
Less than two weeks after making a presentation at the SeeThruEquity Conference in Miami Beach, SeeThruEquity increased its price target for ChineseInvestors.com (OTCQB: CIIX) to $3.75.
Organigram (TSX.V:OGI, OTCQB:OGRMF) began a voluntary recall of a total of 74 products produced between February 1 and December 16, 2016. These lots tested positive for two pesticides that aren't authorized for use on cannabis plants under the Pest Control Products Act but there are long-term benefits for the recall.
Invictus MD Strategies Inc. (CSE:IMH,OTC:IVITF) has a flurry of recent developments as the company builds a portfolio of Canadian licensed producers preparing to move into the recreational market.
The Canadian Bioceutical Corporation (CSE:BCC,OTC:CBICF) announces that it has entered into a Market Making Services Agreement with Venture Liquidity Providers Inc. for an initial 12 month term.
AusCann recently went public via a reverse takeover on the ASX. Their joint-venture with Daya Foundation in Chile and Canopy Growth in Canada puts them at the head of the pack in the Australian market. Canopy Growth Corporation will potentially make the move to buy AusCann.